Literature DB >> 7667646

Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation.

J T Lie1.   

Abstract

Giant cell arteritis (GCA) is closely identified with the temporal arteritis-polymyalgia rheumatica syndrome of the elderly. It is also a systemic disease that can cripple and kill. Up to 15% of patients with temporal arteritis may have angiographic evidence of extracranial GCA, and aortic insufficiency, ruptured aortic aneurysm, aortic dissection, stroke, or myocardial infarction may be the initial manifestation of systemic GCA. A review of 72 cases of aortic and extracranial GCA, all with histopathologic verification of the disease, revealed that 25% of patients with aortic and extracranial large-vessel GCA had asymptomatic temporal arteritis; the ascending aorta and aortic arch were most frequently involved (39%), followed by the subclavian and axillary arteries (26%), and the femoropopliteal arteries (18%). Nine patients (12.5%) underwent an upper or lower limb amputation. Of the 18 patients whose death was directly attributable to extracranial GCA the causes were ruptured aortic aneurysm (6), aortic dissection (6), stroke (3), and myocardial infarction (3). The findings of these 72 cases caution against attributing all aortic and large-vessel arterial disease in the elderly to atherosclerosis and emphasize that timely surgical intervention may be necessary for life-saving and limb-salvage in patients with aortic and extracranial GCA.

Entities:  

Mesh:

Year:  1995        PMID: 7667646     DOI: 10.1016/s0049-0172(95)80010-7

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  43 in total

1.  An ascending aortic aneurysm caused by giant cell arteritis: report of a case.

Authors:  K Hamano; H Gohra; T Katoh; Y Fujimura; N Zempo; Y Nakashima; K Esato
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Giant Cell Arteritis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

Review 3.  Giant cell arteritis.

Authors:  J M Calvo-Romero
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

Review 4.  Lower extremity vasculitis in polymyalgia rheumatica and giant cell arteritis.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

5.  Quality of life of patients treated for giant cell arteritis: a case-control study.

Authors:  Stéphanie Jobard; Julie Magnant; Hélène Blasco; Nicole Ferreira-Maldent; Isabelle Griffoul; Elisabeth Diot; François Maillot
Journal:  Clin Rheumatol       Date:  2017-04-12       Impact factor: 2.980

6.  Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case-control study.

Authors:  Florent L Besson; Hubert de Boysson; Jean-Jacques Parienti; Gérard Bouvard; Boris Bienvenu; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-06       Impact factor: 9.236

7.  Giant cell arteritis and cardiovascular disease in older adults.

Authors:  J G Ray; M M Mamdani; W H Geerts
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

8.  Arterial lesions in giant cell arteritis: A longitudinal study.

Authors:  Tanaz A Kermani; Sehriban Diab; Antoine G Sreih; David Cuthbertson; Renée Borchin; Simon Carette; Lindsy Forbess; Curry L Koening; Carol A McAlear; Paul A Monach; Larry Moreland; Christian Pagnoux; Philip Seo; Robert F Spiera; Kenneth J Warrington; Steven R Ytterberg; Carol A Langford; Peter A Merkel; Nader A Khalidi
Journal:  Semin Arthritis Rheum       Date:  2018-05-09       Impact factor: 5.532

9.  Acute aortitis with spinal artery aneurysms detected by contrast enhanced magnetic resonance imaging.

Authors:  Damir Erkapic; Johannes Rixe; Johannes Strunk; Christian W Hamm; Thorsten Dill
Journal:  Clin Res Cardiol       Date:  2008-08-30       Impact factor: 5.460

10.  A case of polyarteritis nodosa presenting initially as peripheral vascular disease.

Authors:  Serge De Golovine; Sameer Parikh; Lee Lu
Journal:  J Gen Intern Med       Date:  2008-06-17       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.